The Company

MimeTech Srl was incorporated in December of 2004 by two scientists, Antonio Guarna, Professor of Organic Chemistry, and Federico Cozzolino, Professor of Clinical Laboratory Sciences, both at the University of Firenze, to further develop pharmaceutical applications of a novel library of synthetic neurotrophin mimetics.

→ read more

The Technology

At the hub of our technology platform is a cutting-edge series of synthetic neurotrophin mimetics. The flaghship compound, whose name is Negermin, is endowed with potent NGF (Nerve Growth Factor) as well as BDNF (Brain-Derived Neurotrophic Factor) mimetic activity.

→ read more

Therapeutic solutions

Negermin use is primarily proposed for the treatment of ophthalmic diseases, neurodegenerative diseases and cardiovascular diseases.

→ read more

Cardiovascular Diseases

Cardiac arrest, cardiac ischemia, myocardial infarction.

+ Learn more

Neurodegenerative Diseases

Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis.

+ Learn more

Solid Organ Transplant

Heart, kidney, liver, lung.

+ Learn more

Ophthalmic Diseases

Corneal lesions, glaucoma, neurotrophic keratitis.

+ Learn more

Dermatologic Diseases

Pressure ulcers.

+ Learn more

Pet health

Corneal lesions, wound healing.

+ Learn more

Our Partners